The medication is commonly used to help with symptoms related to allergic eye conditions.

This medication is applied in addressing symptom clusters associated with Seasonal Allergic Conjunctivitis (hay fever eyes) and Perennial Allergic Conjunctivitis. It is commonly used to help with symptoms related to ocular discomfort, including intense itching, watering, visible eye redness, and the sensation of grittiness. This application may provide support that helps ease the overall symptom load.

---

Quick Fact: Support for Itching

Property	Benefit Focus
Common Therapeutic Focus	Symptomatic management of ocular allergies
Symptom Focus	Itching, watering, redness, grittiness
Relevant Conditions	Seasonal Allergic Conjunctivitis, Perennial Allergic Conjunctivitis, Vernal Keratoconjunctivitis
Clinical Scenario	Prophylactic support before or during peak season

---

Opticrom Hayfever 2% is also relevant in clinical settings that involve acute or unstable symptom patterns, such as those requiring preventative support before the pollen season begins. It is used for managing conditions such as Seasonal Allergic Conjunctivitis and Perennial Allergic Conjunctivitis, and may be part of symptomatic management for complex manifestations like Vernal Keratoconjunctivitis. Using the preparation preemptively may assist with symptomatic relief, which helps patients cope more steadily with symptom fluctuations and assists with maintaining functional stability.

Regulatory References

1. NIH MedlinePlus overview on Cromolyn Ophthalmic

The eligibility for using Opticrom Hayfever 2% is defined by official regulatory documents, specifying absolute contraindications and conditional use requirements.

Populations for whom use is contraindicated:

• Patients with a known hypersensitivity or allergy to the active substance, sodium cromoglycate, or any of the product's inactive ingredients must not use this medicine.

Age-Related Eligibility

Use is approved for adults (including the elderly) and children over 6 years of age for the 2% ophthalmic solution. Use is not recommended for children under six, and safety is not established for children younger than four years of age.

Conditional Use Limitations

• Soft Contact Lenses: Patients must remove contact lenses prior to application and wait at least 15 minutes before re-insertion due to the presence of the preservative benzalkonium chloride.
• Pregnancy and Lactation: For individuals who are pregnant, the medicine should be used only if clearly needed. Caution should be exercised when using the drops while breastfeeding as excretion into human milk is not confirmed.

The official regulatory profile for Opticrom Hayfever 2% (Sodium Cromoglycate Ophthalmic Solution) is primarily determined by its pharmacokinetic behavior. The active compound is poorly absorbed from the eye, with systemic absorption consistently documented as minimal, typically ranging from approximately 0.03% to 0.07%.

This minimal systemic presence is the basis for the regulatory finding that there are no known clinically significant drug-drug interactions with systemic medicinal products, and the product's official labeling does not list any medicines or substance categories as formally contraindicated due to an interaction risk. Regulatory documents also do not cite any interactions with food, alcohol, or herbal supplements, nor are there documented enzyme-mediated (e.g., CYP) or transporter-based metabolic interactions.

The essential constraint is an administration-timing rule for the local ocular route. Official labeling mandates a minimum 15-minute separation between the instillation of this product and any other ophthalmic solutions to ensure the efficacy of both treatments. This product may be used concurrently with ophthalmic corticosteroids, a co-use pattern noted in regulatory prescribing information. The overall interaction structure is classified by regulatory authorities as lacking systemic interaction potential.

Mast Cell Stabilization: Upstream Pathway Modulation

The mechanism of action for Opticrom Hayfever 2% (Sodium Cromoglicate) functions by influencing core mechanisms associated with cellular activation and mediator release in peripheral tissues. Its primary mechanistic focus is to engage the mast cell membrane, a defined biological target. This upstream interference suppresses signaling sequences that lead to the physical breakdown (degranulation) of these cells, which are storage sites for inflammatory chemicals.

Inhibition of Inflammatory Mediator Release

By stabilizing the mast cell, the mechanism initiates the suppression of the subsequent cascade: it prevents the rapid, excessive release of potent transmitters, such as histamine, alongside other mediators like leukotrienes. This action modifies the early molecular steps that shape systemic physiological outcomes, which limits the impact of excessive mediator activity on tissue surfaces.

Regulating Cellular Signaling Dynamics

At a deeper level, the mechanism is relevant in systems where targeted pathway adjustment is required, specifically by influencing the transmembrane movement of calcium ions ( Ca^2+). By modulating the Ca^2+ influx that normally triggers degranulation, the drug supports a more regulated state within targeted peripheral pathways, contributing to the stabilization of cellular physiological responses, which shapes the overall pharmacological effect profile.

The administration of Opticrom Hayfever 2% is based on official instructions for its use as a sterile ophthalmic solution containing sodium cromoglycate. The medicine is intended solely for topical ocular use, meaning it must be administered directly to the surface of the eye.

Administration Scope

Feature	Official Labeled Guideline
Route of Administration	Topical Ocular Use
Dosing Schedule	Instill one or two drops into each affected eye.
Frequency Pattern	Administered four times daily (QID).
Age-Group Rules	Standard dose for adults and children over 6 years.
Duration Constraint	Continuous use must be limited to 14 days unless under professional advice.

The effect of the medicine is dependent upon its administration at regular intervals throughout the day. For the use pattern over time, therapy should be initiated prophylactically before anticipated allergen exposure and continued consistently throughout the season.

Special Procedural Conditions

Patients wearing soft contact lenses must remove the lenses prior to the dose. Lenses should not be reinserted for at least 15 minutes following the application of the drops. If a dose is forgotten, it should be used as soon as the patient remembers, unless it is nearly time for the next scheduled dose, in which case the missed dose should be skipped to prevent duplication. The recommended frequency of administration must not be exceeded.

Recent Clinical Evidence: Opticrom Hayfever 2%

Opticrom Hayfever 2% contains sodium cromoglycate, a type of medicine classified as a mast cell stabilizer. Clinical studies have investigated the use of this ophthalmic solution in managing symptoms associated with allergic conjunctivitis, commonly known as hay fever eyes.

Efficacy in Symptom Management

Randomized, controlled trials (RCTs) evaluating sodium cromoglycate against a placebo in patients with seasonal allergic conjunctivitis have been conducted. A meta-analysis of several trials suggests that patients using the topical solution were more likely to report perceived benefit compared to those using a placebo. However, analyses note that many of these trials were small, exhibited heterogeneity (variability in study design and participants), and the estimated effect had wide confidence intervals, suggesting uncertainty in the pooled benefit.

Research typically focuses on the reduction of specific ocular symptoms, which often include:

• Ocular itching
• Conjunctival redness
• Tearing (lacrimation)

Safety Profile and Comparative Use

Topical sodium cromoglycate is poorly absorbed into the bloodstream, which is associated with a low incidence of systemic side effects. The most frequently reported localized adverse events in clinical trials include transient stinging or burning upon application. These effects are generally mild.

Comparative studies have been conducted to evaluate sodium cromoglycate against other mast cell stabilizers, such as lodoxamide. Some research has shown similar reductions in symptoms between these agents, while other, smaller studies have suggested differences in the speed of relief or effect on specific signs like papillary hypertrophy. Furthermore, studies have also examined its use in combination with topical corticosteroids for severe cases of allergic eye disease.

Common questions about Opticrom Hayfever 2% (FAQ)

Q: Can Opticrom Hayfever 2% be used for allergies that aren't hay fever?

A: Yes, official product information describes the medicine’s use for general eye allergies (known as allergic conjunctivitis). This includes both seasonal forms, like hay fever, and long-term (perennial) forms of eye allergies caused by different allergens.

Q: Is it normal to feel a slight stinging sensation when I first use the drops?

A: Official safety documents list a transient stinging or burning upon instillation as a common and frequently reported adverse reaction. This effect usually passes quickly after the drops are applied.

Q: Is the active ingredient in Opticrom Hayfever 2% available in any other eye drops?

A: Yes, the active ingredient, sodium cromoglycate (also known as cromolyn sodium), is described as being available in other ophthalmic solutions. It may be marketed under different brand names or as a generic (non-brand name) formulation.

Q: What is the difference between Opticrom Hayfever 2% and eye drops with olopatadine?

A: Clinical research has examined both compounds. Evidence indicates that while sodium cromoglycate acts solely as a mast cell stabilizer, olopatadine is described as having a dual mechanism that includes both mast cell stabilization and antihistamine activity.

Q: Is it possible to have an allergic reaction to Opticrom Hayfever 2% itself?

A: Yes. Official safety documents list hypersensitivity reactions as possible adverse effects. The product is contraindicated (should not be used) for individuals with a known allergy to the active substance or any of its inactive ingredients.

Q: Does Opticrom Hayfever 2% work for itchy eyes or only red eyes?

A: Regulatory documents and studies indicate it is intended to address symptoms of allergic conjunctivitis, which include both ocular itching and conjunctival redness.

Q: Has Opticrom Hayfever 2% been studied in long-term use?

A: Clinical research has been conducted on sodium cromoglycate ophthalmic solution, with some studies focusing on the long-term control of ocular symptoms related to persistent or recurrent allergies. This provides context for its continuous use over an allergy season.

Q: Do studies suggest Opticrom Hayfever 2% is better used before symptoms start?

A: Due to its mechanism as a mast cell stabilizer (a preventative agent), official consumer information states that the medicine’s use should be started prophylactically (preventatively) before exposure to allergens. This approach is consistent with the drug's mechanism of action, which works proactively as a preventative agent.

Q: What kind of research evidence is there for Opticrom Hayfever 2%?

A: Research has included randomized, controlled trials and meta-analyses investigating the topical solution's effect on common allergic eye symptoms. These studies focus on outcomes like the reduction of itching, redness, and tearing.

Q: Will Opticrom Hayfever 2% help with puffiness or swelling around the eyes?

A: Official product information notes that the drops are used to relieve symptoms of eye allergy, which include inflamed or puffy eyelids.

Q: Is there a generic version of Opticrom Hayfever 2% available?

A: Yes, the active substance, sodium cromoglycate, is available in generic ophthalmic solution form. Generic products often provide a lower-cost alternative to the brand name preparation.

Q: Why do official documents mention continuous use for full effect?

A: Continuous use is mentioned because the product is classified as a mast cell stabilizer. This means it works proactively to prevent the release of inflammatory chemicals, requiring consistent use to maintain that preventative barrier against the allergic response.

Q: Can Opticrom Hayfever 2% be used for irritation from pet dander?

A: Official consumer information lists the product's use for eye allergies caused by exposure to various common allergens. These substances include animal dander, house dust, and pollens.

Q: Is there a link between using Opticrom Hayfever 2% and eye infections?

A: Regulatory documents do not state a direct link. However, official instructions emphasize the importance of maintaining the sterility of the solution by avoiding contact between the dropper tip and the eye or any other surface, which helps minimize the potential for contamination.

Q: Can Opticrom Hayfever 2% be used on toddlers?

A: The 2% ophthalmic solution is formally approved for use in adults and children over 6 years of age. Official documents indicate that safety for use in children younger than four years of age is not established.

Q: Is it true that Opticrom Hayfever 2% is generally well tolerated?

A: The safety profile, supported by clinical trials, is associated with a low incidence of systemic side effects. The most frequently reported effects are transient and occur only at the site of application. These characteristics are consistent with a generally well-tolerated drug profile.

Q: Will Opticrom Hayfever 2% interact with blood pressure medications?

A: Due to the medicine’s minimal systemic absorption into the bloodstream, the regulatory profile indicates there are no known clinically significant drug-drug interactions with systemic medicinal products, including blood pressure medications.

Q: Can I use Opticrom Hayfever 2% for non-allergic eye irritation?

A: The product is officially indicated for the management of symptoms associated with allergic conjunctivitis. Consumer information states it should only be used for allergic conditions of the eye.

Q: Does the effectiveness of Opticrom Hayfever 2% decrease over time?

A: Clinical research has included studies on the long-term control of symptoms, suggesting stability of the preventative effect when used as recommended. Official instructions emphasize continuous use throughout the season to maintain the benefit.

Q: How long does Opticrom Hayfever 2% take to start working?

A: Some reports indicate the drops can begin to provide relief for certain symptoms in as little as two minutes. However, due to its preventative nature, it may take a few days to weeks of regular use to observe the product's full prophylactic (preventative) effects.

Q: Do I have to use Opticrom Hayfever 2% all season long?

A: Official consumer information advises that the drops should be used continually throughout the allergy season, even when symptoms are not present. This continuous use helps to maintain the drug’s preventative effect on the mast cells.

Q: What happens if I stop using Opticrom Hayfever 2% suddenly?

A: Official documents note that the medicine is used prophylactically (preventatively). If the use of the drops is discontinued, the original allergy symptoms may return.

Q: Is Opticrom Hayfever 2% suitable for people who wear contact lenses?

A: The official labeling includes a precaution that soft contact lenses should not be worn during treatment due to the preservative benzalkonium chloride. Lenses must be removed prior to application and can be reinserted only after 15 minutes.

Q: Will Opticrom Hayfever 2% make my vision blurry?

A: Regulatory safety information lists blurring of vision as a potential side effect. This effect is usually described as being transient and occurs immediately after the drops are applied.

Q: Can Opticrom Hayfever 2% affect driving or operating machinery?

A: Because the drops may cause temporary blurring of eyesight immediately after use, official documents state that one should not drive or operate tools or machinery until vision is clear.

Q: What happens if I accidentally put more drops in than recommended?

A: Regulatory information notes that there have been no reported cases in humans of overdose with the product. In the event more drops are used than recommended, official documentation suggests contacting a healthcare professional or poison control center.

Q: What is the expected duration of action after putting in the drops?

A: The recommended four times daily frequency pattern in official instructions is intended to maintain a consistent concentration of the active substance over the course of the day. This schedule is designed to keep the preventative effect active.

Q: What should I do if the bottle tip touches my eye?

A: To maintain the sterility of the drops, official instructions advise avoiding contact between the dropper tip and any surface. Some medical guidance notes that if the tip inadvertently touches the ocular surface, the multi-dose container is to be discarded to help prevent contamination.

Q: How does the cromoglicate in Opticrom Hayfever 2% compare to that in nasal sprays?

A: The active ingredient, sodium cromoglycate, is available in different medical formulations, including ophthalmic solution (eye drops) and nasal sprays. The eye drops are specifically noted for having minimal systemic absorption into the body.

Q: Do I need a prescription to buy Opticrom Hayfever 2%?

A: The regulatory status can vary by region. The product is frequently classified as a non-prescription (over-the-counter) medicine for the temporary relief of seasonal eye allergy symptoms in many countries.

Storage Conditions

Official regulatory guidelines define specific storage requirements for Opticrom Hayfever 2% eye drops based on the container type.

Container Type	Required Storage Condition
Multi-dose Bottle (Opened)	Do not store above 25°C. Must be properly closed after each use.
Single-dose Vials	Store below 25°C. Keep in the aluminum sachet to protect from light.

The stability of the solution is tied to first use. The multi-dose bottle must be discarded four weeks (28 days) after initial opening. A single-dose container must be used immediately after being opened and should not be used again. All preparations must be kept out of the sight and reach of children.

Disposal Instructions

Unused or expired Opticrom Hayfever 2% must not be disposed of via household waste or wastewater. The product and any waste material must be discarded in accordance with local requirements for pharmaceutical waste.